Safety and efficacy of a traditional herbal medicine (Throat Coat) in symptomatic temporary relief of pain in patients with acute pharyngitis: a multicenter, prospective, randomized, double-blinded, placebo-controlled study - PubMed (original) (raw)
Clinical Trial
Safety and efficacy of a traditional herbal medicine (Throat Coat) in symptomatic temporary relief of pain in patients with acute pharyngitis: a multicenter, prospective, randomized, double-blinded, placebo-controlled study
Josef Brinckmann et al. J Altern Complement Med. 2003 Apr.
Abstract
Objective: To investigate the safety and efficacy of Throat Coat) (Traditional Medicinals,) Sebastopol, CA), a traditional demulcent herbal tea, in comparison with a placebo tea in the symptomatic treatment of acute pharyngitis.
Design: Multicenter, prospective, randomized, double-blinded, placebo-controlled, two-armed, parallel-group clinical trial.
Settings: Three primary care clinics in Duluth, MN, Madison, WI, and Middleton, WI.
Subjects: Patients of both genders (>or=18 years of age) with clinical diagnoses of acute pharyngitis.
Interventions: Patients (n = 60) were randomly assigned to receive 5-8 oz of Throat Coat (n = 30) or a placebo (n = 30), four to six times daily. The study period was 2 to 7 days with a window for the follow-up visit of 2-10 days accounting for the variable duration of sore throat symptoms.
Outcome measures: Primary efficacy parameter: sum of pain intensity differences (SPID) for pain in throat on swallowing, calculated as the area under the curve (AUC) of pain intensity difference scores (assessed at 1 minute, 5 minutes, 10 minutes, 15 minutes, 20 minutes, and 30 minutes after treatment). Secondary efficacy parameter: total pain relief (TOTPAR), calculated as the AUC from time 0 (baseline) to 30 minutes of pain relief (assessed at 1 minute, 5 minutes, 10 minutes, 15 minutes, 20 minutes, and 30 minutes).
Results: Compared to placebo, intensity of throat pain when swallowing was significantly reduced by Throat Coat in intention to treat and valid for efficacy analysis (VEA). Significant differences in change from baseline pain were observed at 5 min (p = 0.007), 10 min (p = 0.005), 15 minutes (p = 0.01), 20 minutes (p = 0.05), and 30 minutes (p = 0.04) after completion of the first dose (VEA analysis). There was a statistically significant improvement of SPID in the Throat Coat-treated group: Least square means +/- standard error of the means (SEM) of SPID were -16.5 +/- 13.9 in the placebo group and -43.8 +/- 11.9 in the Throat Coat-treated group (p = 0.012). TOTPAR was also significantly higher in the Throat Coat-treated group: Least square means +/- SEM of TOTPAR were 32.4 +/- 12.8 in the placebo group and 53.6 +/- 10.9 in the Throat Coat-treated group (p = 0.031). This study shows that Throat Coat is significantly superior to placebo and provided a rapid, temporary relief of sore throat pain in patients with pharyngitis.
Similar articles
- Efficacy and safety of Qi-Wei-Qing-Yan aerosol in treatment of acute pharyngitis (lung-stomach excess-heat syndrome): study protocol for a randomized controlled trial.
Jiang HL, She B, Liu W, Mao B, Zhang JY. Jiang HL, et al. Trials. 2016 Feb 19;17:99. doi: 10.1186/s13063-016-1217-4. Trials. 2016. PMID: 26896352 Free PMC article. Clinical Trial. - Lidocaine 8 mg sore throat lozenges in the treatment of acute pharyngitis. A new therapeutic option investigated in comparison to placebo treatment.
Wonnemann M, Helm I, Stauss-Grabo M, Röttger-Luer P, Tran CT, Canenbley R, Donath F, Nowak H, Schug BS, Blume HH. Wonnemann M, et al. Arzneimittelforschung. 2007;57(11):689-97. doi: 10.1055/s-0031-1296669. Arzneimittelforschung. 2007. PMID: 18193690 Clinical Trial. - Efficacy of AMC/DCBA lozenges for sore throat: A systematic review and meta-analysis.
Weckmann G, Hauptmann-Voß A, Baumeister SE, Klötzer C, Chenot JF. Weckmann G, et al. Int J Clin Pract. 2017 Oct;71(10). doi: 10.1111/ijcp.13002. Epub 2017 Sep 4. Int J Clin Pract. 2017. PMID: 28869700 Review. - Assay sensitivity of pain intensity versus pain relief in acute pain clinical trials: ACTTION systematic review and meta-analysis.
Singla N, Hunsinger M, Chang PD, McDermott MP, Chowdhry AK, Desjardins PJ, Turk DC, Dworkin RH. Singla N, et al. J Pain. 2015 Aug;16(8):683-91. doi: 10.1016/j.jpain.2015.03.015. Epub 2015 Apr 16. J Pain. 2015. PMID: 25892656 Review.
Cited by
- Efficacy and safety of Qi-Wei-Qing-Yan aerosol in treatment of acute pharyngitis (lung-stomach excess-heat syndrome): study protocol for a randomized controlled trial.
Jiang HL, She B, Liu W, Mao B, Zhang JY. Jiang HL, et al. Trials. 2016 Feb 19;17:99. doi: 10.1186/s13063-016-1217-4. Trials. 2016. PMID: 26896352 Free PMC article. Clinical Trial. - Potentials of Antitussive Traditional Persian Functional Foods for COVID-19 Therapy†.
Mosleh G, Badr P, Zaeri M, Mohagheghzadeh A. Mosleh G, et al. Front Pharmacol. 2021 Jul 16;12:624006. doi: 10.3389/fphar.2021.624006. eCollection 2021. Front Pharmacol. 2021. PMID: 34335237 Free PMC article. Review. - Treatment of upper respiratory tract infections in primary care: a randomized study using aromatic herbs.
Ben-Arye E, Dudai N, Eini A, Torem M, Schiff E, Rakover Y. Ben-Arye E, et al. Evid Based Complement Alternat Med. 2011;2011:690346. doi: 10.1155/2011/690346. Epub 2010 Nov 1. Evid Based Complement Alternat Med. 2011. PMID: 21052500 Free PMC article. - Group A β-hemolytic Streptococcal Pharyngitis: An Updated Review.
Leung AKC, Lam JM, Barankin B, Leong KF, Hon KL. Leung AKC, et al. Curr Pediatr Rev. 2024;21(1):2-17. doi: 10.2174/1573396320666230726145436. Curr Pediatr Rev. 2024. PMID: 37493159 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical